Dishman Carbogen Amcis Limited

BSE: 540701 NSE: DCAL
Dishman Carbogen Amcis Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials and compliance.
CIN L74900GJ2007PLC051338 Incorporated 17 July 2007 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Listed - NSE: DCAL · BSE: 540701 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹2,931.9 Cr
▲ 8.13% YoY
Computed EBITDA · FY 2026
₹621.57 Cr
▲ 26.69% YoY
Net profit · FY 2026
₹97.45 Cr
▲ 2907.72% YoY
Authorised capital
₹38 Cr
Registered with MCA
Paid-up capital
₹31.36 Cr
Issued & subscribed
Open charges
₹1,609.35 Cr
Satisfied ₹879.25 Cr
Company age
19 yrs
Est. 2007
Last financials
Mar 2025
Balance sheet date

About Dishman Carbogen Amcis Limited

Data last updated: 02 July 2026

Dishman Carbogen Amcis Limited is a public limited company based in Ahmedabad, Gujarat, India, a subsidiary of Adimans Technologies Llp. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 17 July 2007, the company has been in operation for over 19 years.

Registered with ROC Ahmedabad under CIN L74900GJ2007PLC051338. Listed on BSE: 540701 and NSE: DCAL.

Capital: an authorised share capital of ₹38 Cr and a paid-up capital of ₹31.36 Cr. It is led by directors including Arpit Janmejay Vyas and Deohooti Janmejay Vyas.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Dishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058.

As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹2,931.9 Cr, a growth of 8.13% compared to the previous year. The net worth stands at ₹6,676.9 Cr (up 14.5% YoY). Total assets are valued at ₹11,923 Cr (up 19.24% YoY).

It operates as a subsidiary of Adimans Technologies Llp. Its group structure includes 2 subsidiaries.

The company is associated with 2 brands - Dishman Group, Dishman Carbogen Amcis. As per MCA filings, the company has open charges of ₹1,609.35 Cr and satisfied charges of ₹879.25 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dishmangroup.com.

Company Details of Dishman Carbogen Amcis Limited
CIN L74900GJ2007PLC051338
Registration Number 051338
Incorporation Date 17 July 2007
ROC Ahmedabad
Listing Status Listed (BSE: 540701, NSE: DCAL)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Adimans Technologies Llp
Compliance Status Active Compliant
Key People
Arpit Janmejay Vyas Managing Director Deohooti Janmejay Vyas Whole-Time Director Harshil Ramakant Dalal Cfo
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    dishmangroup.com
  • Social Media
  • Registered Address
    Dishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058
  • Industry
    Pharma, API Manufacturers
Company report
Dishman Carbogen Amcis Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Dishman Carbogen Amcis Limited report

Financials, compliance, directors, charges, ownership and filings for Dishman Carbogen Amcis Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited has one previous CIN (Corporate Identification Number): U74900GJ2007FLC051338. The current CIN is L74900GJ2007PLC051338, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L74900GJ2007PLC051338 Current
U74900GJ2007FLC051338 Previous

Associated Brands with Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited operates two associated brands: Dishman Group and Dishman Carbogen Amcis. These brands represent Dishman Carbogen Amcis Limited's diversified market presence and brand portfolio.

Brand Description Website
Dishman Group
CDMO offering its services for the development of APIs and intermediates dishmangroup.com
Dishman Carbogen Amcis
Active pharmaceutical ingredients are manufactured by the CDMO in India. imdcal.com

Competitors & Alternatives of Dishman Carbogen Amcis Limited

Brands and companies operating in the same space as Dishman Carbogen Amcis Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Dishman Carbogen Amcis Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited is audited by T R CHADHA & CO. LLP (ICAI peer reviewed, certificate valid till 2028-09-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
T R CHADHA & CO. LLP (ICAI peer reviewed, certificate valid till 2028-09-30) FY 2026 Declaration of unmodified opinion

Board of Directors and KMP of Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited currently reports 6 directors and 1 key managerial person. 8 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Arpit Janmejay Vyas
Also directs: Dishman Biotech Limited, Rtv Technochem Private Limited, Leon Hospitality Private Limited and 5 more
Managing Director 07 Apr 2012 14 Years 4 Months Current
Harshil Ramakant Dalal
Also directs: Dishman Medicare Limited, Aham Brahmasmi Entertainment Private Limited
Cfo 28 Nov 2018 7 Years 8 Months Current
Deohooti Janmejay Vyas
Also directs: Adimans Technologies Llp, B R Laboratories Limited, Dishman Biotech Limited and 5 more
Whole-Time Director 17 Mar 2017 9 Years 5 Months Current
Dhaval Rameshchandra Shah Director 12 Aug 2025 1 Years 0 Months Current
Hemantkumar Jayantiprasad Bhatt
Also directs: Transpek Creative Chemistry Private Limited
Director 01 Apr 2025 1 Years 4 Months Current
Margie Parikh Director 01 Apr 2025 1 Years 4 Months Current
Showing 6 of 7 current directors and KMP. View all directors and KMP

Financials of Dishman Carbogen Amcis Limited FY 2026 filings available

Dishman Carbogen Amcis Limited reported revenue of ₹2,931.9 Cr (up 8.13% YoY) for FY 2026.

Revenue · FY 2026
₹2,931.9 Cr ▲ 8.13%
Profit · FY 2026
₹97.45 Cr ▲ 2907.72%
Computed EBITDA · FY 2026
₹621.57 Cr ▲ 26.69%
Revenue₹ Cr · Consolidated01,0002,0003,000FY 2020: ₹2,044 Cr2,044FY 2020FY 2021: ₹1,912 Cr · -6.4% YoY1,912-6.4%FY 2021FY 2022: ₹2,141 Cr · +12% YoY2,141+12%FY 2022FY 2023: ₹2,413 Cr · +12.7% YoY2,413+12.7%FY 2023FY 2024: ₹2,616 Cr · +8.4% YoY2,616+8.4%FY 2024FY 2025: ₹2,712 Cr · +3.7% YoY2,712+3.7%FY 2025FY 2026: ₹2,932 Cr · +8.1% YoY2,932+8.1%FY 2026
Net Profit₹ Cr · Consolidated-200-1000100200FY 2020: ₹180 Cr180FY 2020FY 2021: ₹165 Cr (loss) · -191.6% YoY-165FY 2021FY 2022: ₹18 Cr · +110.9% YoY18+110.9%FY 2022FY 2023: ₹30 Cr (loss) · -265.5% YoY-29.8FY 2023FY 2024: ₹153 Cr (loss) · -414.9% YoY-153FY 2024FY 2025: ₹3 Cr · +102.1% YoY3.2+102.1%FY 2025FY 2026: ₹97 Cr · +2907.7% YoY97.5+2907.7%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year05001,000Q1'25: ₹524 Cr · -27.6% YoY524-27.6%Q1'25Q2'25: ₹789 Cr · +34.5% YoY789+34.5%Q2'25Q3'25: ₹682 Cr · +4.8% YoY682+4.8%Q3'25Q4'25: ₹716 Cr · +9.4% YoY716+9.4%Q4'25Q1'26: ₹708 Cr · +35.2% YoY708+35.2%Q1'26Q2'26: ₹653 Cr · -17.3% YoY653-17.3%Q2'26Q3'26: ₹720 Cr · +5.5% YoY720+5.5%Q3'26Q4'26: ₹851 Cr · +18.9% YoY851+18.9%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹2,931.9 Cr ₹2,711.5 Cr ₹2,615.77 Cr ₹2,412.92 Cr ₹2,140.69 Cr ₹1,912.03 Cr ₹2,043.6 Cr
Other Income ₹55.94 Cr ₹21.68 Cr ₹28.21 Cr ₹27.77 Cr ₹43.42 Cr ₹38.45 Cr ₹44.46 Cr
Total Income ₹2,987.84 Cr ₹2,733.18 Cr ₹2,643.98 Cr ₹2,440.69 Cr ₹2,184.11 Cr ₹1,950.48 Cr ₹2,088.06 Cr
Cost of Materials Consumed ₹487.85 Cr ₹592.96 Cr ₹601.21 Cr ₹624.99 Cr ₹460.5 Cr ₹421.86 Cr ₹464.41 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories -₹79.06 Cr -₹91.31 Cr -₹4.02 Cr -₹113.58 Cr -₹13.08 Cr ₹46.29 Cr -₹30.57 Cr
Employee Benefit Expense ₹1,446.93 Cr ₹1,293.57 Cr ₹1,208.16 Cr ₹1,035.27 Cr ₹981.49 Cr ₹872.91 Cr ₹762.27 Cr
Finance Costs ₹174.18 Cr ₹159.46 Cr ₹119.97 Cr ₹85.69 Cr ₹56.81 Cr ₹47.61 Cr ₹61.95 Cr
Depreciation & Amortisation ₹338.69 Cr ₹293.74 Cr ₹310.86 Cr ₹280.72 Cr ₹307.59 Cr ₹307.94 Cr ₹282.87 Cr
Other Expenses ₹510.55 Cr ₹447.34 Cr ₹523.92 Cr ₹534.04 Cr ₹380.41 Cr ₹296.62 Cr ₹325.05 Cr
Total Expenses ₹2,879.14 Cr ₹2,695.76 Cr ₹2,760.1 Cr ₹2,447.13 Cr ₹2,173.72 Cr ₹1,993.23 Cr ₹1,865.98 Cr
Profit Before Exceptional Items & Tax ₹108.7 Cr ₹37.42 Cr -₹116.12 Cr -₹6.44 Cr ₹10.39 Cr -₹42.75 Cr ₹222.08 Cr
Exceptional Items -₹3.8 Cr -₹18.11 Cr -₹6.14 Cr -₹48.15 Cr -₹14.64 Cr -₹22.28 Cr ₹0
Profit Before Tax ₹104.9 Cr ₹19.31 Cr -₹122.26 Cr -₹54.59 Cr -₹4.25 Cr -₹65.03 Cr ₹222.08 Cr
Total Tax Expense ₹7.45 Cr ₹16.07 Cr ₹31.19 Cr -₹24.79 Cr -₹22.26 Cr ₹100.1 Cr ₹41.78 Cr
Net Profit ₹97.45 Cr ₹3.24 Cr -₹153.45 Cr -₹29.8 Cr ₹18.01 Cr -₹165.13 Cr ₹180.3 Cr
  attributable to Owners ₹97.45 Cr ₹3.24 Cr -₹153.45 Cr -₹29.8 Cr ₹18.01 Cr -₹165.13 Cr ₹180.3 Cr
  attributable to NCI ₹0 - ₹0 - - ₹0 ₹0
Other Comprehensive Income ₹747.92 Cr ₹200.77 Cr -₹28.75 Cr ₹290.54 Cr -₹164.2 Cr ₹129.9 Cr ₹210.86 Cr
Total Comprehensive Income ₹845.37 Cr ₹204.01 Cr -₹182.2 Cr ₹260.74 Cr -₹146.19 Cr -₹35.23 Cr ₹391.16 Cr
EBITDA (computed) ₹621.57 Cr ₹490.62 Cr ₹314.71 Cr ₹359.97 Cr ₹374.79 Cr ₹312.8 Cr ₹566.9 Cr
Basic EPS ₹6.22 ₹0.21 ₹-9.79 ₹-1.90 ₹1.15 ₹-10.53 ₹11.20
Diluted EPS ₹6.22 ₹0.21 ₹-9.79 ₹-1.90 ₹1.15 ₹-10.53 ₹11.20
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹11,923 Cr ₹9,999.15 Cr ₹9,581.41 Cr ₹9,453.5 Cr
Non-current Assets ₹9,081.21 Cr ₹7,798.73 Cr ₹7,653.22 Cr ₹7,535.14 Cr
Current Assets ₹2,842.1 Cr ₹2,200.42 Cr ₹1,928.19 Cr ₹1,918.36 Cr
Property, Plant & Equipment ₹2,941.93 Cr ₹2,683.86 Cr ₹2,459.09 Cr ₹1,960.93 Cr
Inventories ₹1,019.12 Cr ₹900.24 Cr ₹882.89 Cr ₹803.8 Cr
Trade Receivables ₹672.91 Cr ₹665.14 Cr ₹461.11 Cr ₹589.91 Cr
Cash & Equivalents ₹787.76 Cr ₹341.07 Cr ₹264.09 Cr ₹131.79 Cr
Equity (Net Worth) ₹6,676.9 Cr ₹5,831.52 Cr ₹5,627.5 Cr ₹5,809.67 Cr
Equity Share Capital ₹31.36 Cr ₹31.36 Cr ₹31.36 Cr ₹31.36 Cr
Borrowings (Non-current) ₹1,534.86 Cr ₹1,149.19 Cr ₹245.61 Cr ₹1,046.65 Cr
Borrowings (Current) ₹1,240.54 Cr ₹934.72 Cr ₹1,718.79 Cr ₹777.86 Cr
Total Debt (computed) ₹2,775.4 Cr ₹2,083.91 Cr ₹1,964.4 Cr ₹1,824.51 Cr
Current Liabilities ₹2,317.05 Cr ₹1,924.79 Cr ₹2,554.72 Cr ₹1,798.39 Cr
Total Liabilities ₹5,246.41 Cr ₹4,167.63 Cr ₹3,953.91 Cr ₹3,643.83 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹491.45 Cr ₹375.23 Cr ₹383.97 Cr ₹220.34 Cr ₹354.86 Cr
Investing Cash Flow -₹245.34 Cr -₹192.21 Cr -₹229.52 Cr -₹448.46 Cr -₹618.53 Cr
Financing Cash Flow ₹200.58 Cr -₹102.09 Cr -₹22.15 Cr ₹249.67 Cr ₹130.37 Cr
Capital Expenditure ₹265.98 Cr ₹216.76 Cr ₹303.25 Cr ₹574.06 Cr ₹463.8 Cr
Free Cash Flow (computed) ₹225.47 Cr ₹158.47 Cr ₹80.72 Cr -₹353.72 Cr -₹108.94 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash ₹446.69 Cr ₹76.98 Cr ₹264.09 Cr ₹21.55 Cr -₹133.3 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹851.4 Cr ₹719.8 Cr ₹652.65 Cr ₹708.05 Cr ₹716.34 Cr ₹682.34 Cr ₹789.04 Cr ₹523.78 Cr ₹654.71 Cr ₹651.09 Cr ₹586.59 Cr ₹723.38 Cr
Other Income ₹16.42 Cr ₹6.66 Cr ₹8.11 Cr ₹24.75 Cr ₹7.97 Cr ₹5.63 Cr ₹6.65 Cr ₹1.43 Cr ₹7.16 Cr ₹6.05 Cr ₹8.47 Cr ₹6.53 Cr
Total Income ₹867.82 Cr ₹726.46 Cr ₹660.76 Cr ₹732.8 Cr ₹724.31 Cr ₹687.97 Cr ₹795.69 Cr ₹525.21 Cr ₹661.87 Cr ₹657.14 Cr ₹595.06 Cr ₹729.91 Cr
Cost of Materials Consumed ₹120.36 Cr ₹127.79 Cr ₹34.1 Cr ₹205.6 Cr ₹154.15 Cr ₹161.58 Cr ₹216.09 Cr ₹61.14 Cr ₹158.72 Cr ₹202.53 Cr ₹137.87 Cr ₹102.09 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹14.55 Cr ₹13.69 Cr ₹21 Lakh -₹107.51 Cr -₹8.24 Cr -₹62.75 Cr -₹25.53 Cr ₹5.21 Cr ₹22.69 Cr -₹84.41 Cr -₹3.52 Cr ₹61.22 Cr
Employee Benefit Expense ₹406.21 Cr ₹355.88 Cr ₹332.94 Cr ₹351.9 Cr ₹324.94 Cr ₹332.08 Cr ₹319.73 Cr ₹316.82 Cr ₹320.77 Cr ₹309.2 Cr ₹283.06 Cr ₹295.13 Cr
Finance Costs ₹43.3 Cr ₹45.79 Cr ₹42.33 Cr ₹42.76 Cr ₹42.12 Cr ₹48.78 Cr ₹36.63 Cr ₹31.93 Cr ₹30.95 Cr ₹33.08 Cr ₹27.49 Cr ₹28.45 Cr
Depreciation & Amortisation ₹88.79 Cr ₹84.42 Cr ₹84.13 Cr ₹81.35 Cr ₹79.09 Cr ₹71.97 Cr ₹72.09 Cr ₹70.59 Cr ₹85 Cr ₹80.37 Cr ₹75.04 Cr ₹70.45 Cr
Other Expenses ₹147.33 Cr ₹109.33 Cr ₹136.51 Cr ₹117.38 Cr ₹92.8 Cr ₹111.3 Cr ₹131.6 Cr ₹111.64 Cr ₹89.85 Cr ₹182.66 Cr ₹108.33 Cr ₹143.08 Cr
Total Expenses ₹820.54 Cr ₹736.9 Cr ₹630.22 Cr ₹691.48 Cr ₹684.86 Cr ₹662.96 Cr ₹750.61 Cr ₹597.33 Cr ₹707.98 Cr ₹723.43 Cr ₹628.27 Cr ₹700.42 Cr
Profit Before Exceptional Items & Tax ₹47.28 Cr -₹10.44 Cr ₹30.54 Cr ₹41.32 Cr ₹39.45 Cr ₹25.01 Cr ₹45.08 Cr -₹72.12 Cr -₹46.11 Cr -₹66.29 Cr -₹33.21 Cr ₹29.49 Cr
Exceptional Items -₹1.15 Cr ₹0 ₹0 -₹2.65 Cr -₹11.75 Cr ₹2.04 Cr -₹2.96 Cr -₹5.44 Cr -₹3.09 Cr ₹0 -₹3.05 Cr ₹0
Profit Before Tax ₹46.13 Cr -₹10.44 Cr ₹30.54 Cr ₹38.67 Cr ₹27.7 Cr ₹27.05 Cr ₹42.12 Cr -₹77.56 Cr -₹49.2 Cr -₹66.29 Cr -₹36.26 Cr ₹29.49 Cr
Total Tax Expense ₹24.39 Cr ₹2.53 Cr -₹34.73 Cr ₹15.26 Cr -₹15.39 Cr ₹22.42 Cr ₹9.03 Cr ₹1 Lakh ₹20.72 Cr -₹6.66 Cr ₹4.64 Cr ₹12.49 Cr
Net Profit ₹21.74 Cr -₹12.97 Cr ₹65.27 Cr ₹23.41 Cr ₹43.09 Cr ₹4.63 Cr ₹33.09 Cr -₹77.57 Cr -₹69.92 Cr -₹59.63 Cr -₹40.9 Cr ₹17 Cr
  attributable to Owners ₹21.74 Cr -₹12.97 Cr ₹65.27 Cr ₹23.41 Cr ₹43.09 Cr ₹4.63 Cr ₹33.09 Cr -₹77.57 Cr -₹69.92 Cr -₹59.63 Cr -₹40.9 Cr -
  attributable to NCI ₹0 ₹0 ₹0 ₹0 - ₹0 - ₹0 ₹0 - - -
Other Comprehensive Income ₹227.04 Cr ₹76.12 Cr ₹116.17 Cr ₹328.59 Cr ₹220.36 Cr -₹173.33 Cr ₹147.77 Cr ₹5.97 Cr -₹288.6 Cr ₹274.77 Cr -₹55.62 Cr ₹40.7 Cr
Total Comprehensive Income ₹248.78 Cr ₹63.15 Cr ₹181.44 Cr ₹352 Cr ₹263.45 Cr -₹168.7 Cr ₹180.86 Cr -₹71.6 Cr -₹358.52 Cr ₹215.14 Cr -₹96.52 Cr ₹57.7 Cr
EBITDA (computed) ₹179.37 Cr ₹119.77 Cr ₹157 Cr ₹165.43 Cr ₹160.66 Cr ₹145.76 Cr ₹153.8 Cr ₹30.4 Cr ₹69.84 Cr ₹47.16 Cr ₹69.32 Cr ₹128.39 Cr
Basic EPS ₹1.39 ₹-0.83 ₹4.16 ₹1.49 ₹2.75 ₹0.30 ₹2.11 ₹-4.95 ₹-4.46 ₹-3.80 ₹-2.61 ₹1.08
Diluted EPS ₹1.39 ₹-0.83 ₹4.16 ₹1.49 ₹2.75 ₹0.30 ₹2.11 ₹-4.95 ₹-4.46 ₹-3.80 ₹-2.61 ₹1.08
Latest 12 quarters shown of 25 on record.
Segment · FY 2022 (annual) Revenue Result (PBIT) Assets Liabilities
CRAMS ₹1,649.34 Cr -₹26.58 Cr - -
OTHERS ₹491.35 Cr ₹68.79 Cr - -
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹231.56 Cr ₹399.84 Cr ₹327.35 Cr ₹402.55 Cr ₹302.79 Cr ₹208.01 Cr ₹580.74 Cr
Other Income ₹84.52 Cr ₹32.98 Cr ₹63.05 Cr ₹52.16 Cr ₹65.71 Cr ₹66.15 Cr ₹69.55 Cr
Total Income ₹316.08 Cr ₹432.82 Cr ₹390.4 Cr ₹454.71 Cr ₹368.5 Cr ₹274.16 Cr ₹650.29 Cr
Cost of Materials Consumed ₹55.67 Cr ₹117.01 Cr ₹107.7 Cr ₹163.35 Cr ₹104.6 Cr ₹86.54 Cr ₹180.15 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹2.51 Cr ₹0 ₹0
Changes in Inventories -₹16.36 Cr ₹14 Cr ₹8.27 Cr ₹8 Cr -₹7.7 Cr ₹21.9 Cr ₹19.96 Cr
Employee Benefit Expense ₹86.63 Cr ₹90.15 Cr ₹91.54 Cr ₹86.13 Cr ₹80.54 Cr ₹59.4 Cr ₹88.87 Cr
Finance Costs ₹86.52 Cr ₹70.4 Cr ₹68.19 Cr ₹57.92 Cr ₹37.23 Cr ₹34.17 Cr ₹47.02 Cr
Depreciation & Amortisation ₹62.57 Cr ₹65.2 Cr ₹101.61 Cr ₹96.2 Cr ₹140.07 Cr ₹143.21 Cr ₹140.65 Cr
Other Expenses ₹100.3 Cr ₹106.89 Cr ₹113.04 Cr ₹137.31 Cr ₹88.65 Cr ₹97.63 Cr ₹118.18 Cr
Total Expenses ₹375.33 Cr ₹463.65 Cr ₹490.35 Cr ₹548.91 Cr ₹445.9 Cr ₹442.85 Cr ₹594.83 Cr
Profit Before Exceptional Items & Tax -₹59.25 Cr -₹30.83 Cr -₹99.95 Cr -₹94.2 Cr -₹77.4 Cr -₹168.69 Cr ₹55.46 Cr
Exceptional Items ₹0 ₹0 -₹3.05 Cr -₹2 Cr -₹5.91 Cr ₹0 ₹0
Profit Before Tax -₹59.25 Cr -₹30.83 Cr -₹103 Cr -₹96.2 Cr -₹83.31 Cr -₹168.69 Cr ₹55.46 Cr
Total Tax Expense -₹20.85 Cr -₹20.96 Cr -₹26.59 Cr -₹37.33 Cr -₹52.84 Cr ₹64.12 Cr ₹16.94 Cr
Net Profit -₹38.4 Cr -₹9.87 Cr -₹76.41 Cr -₹58.87 Cr -₹31.55 Cr -₹232.81 Cr ₹38.52 Cr
Other Comprehensive Income -₹109.86 Cr -₹12.23 Cr ₹14.69 Cr -₹58.61 Cr -₹407.61 Cr ₹113.9 Cr -₹94.94 Cr
Total Comprehensive Income -₹148.26 Cr -₹22.1 Cr -₹61.72 Cr -₹117.48 Cr -₹439.16 Cr -₹118.91 Cr -₹56.42 Cr
EBITDA (computed) ₹89.84 Cr ₹104.77 Cr ₹69.85 Cr ₹59.92 Cr ₹99.9 Cr ₹8.69 Cr ₹243.13 Cr
Basic EPS ₹-2.45 ₹-0.63 ₹-4.87 ₹-3.75 ₹-2.01 ₹-14.85 ₹2.46
Diluted EPS ₹-2.45 ₹-0.06 ₹-4.87 ₹-3.75 ₹-2.01 ₹-14.85 ₹2.46
Metrics FY 2026 FY 2025 FY 2024 FY 2023
Total Assets ₹5,126.04 Cr ₹5,122.35 Cr ₹5,076.66 Cr ₹5,181.04 Cr
Non-current Assets ₹4,436.34 Cr ₹4,447.37 Cr ₹4,489.44 Cr ₹4,531.43 Cr
Current Assets ₹689.7 Cr ₹674.98 Cr ₹587.22 Cr ₹649.61 Cr
Property, Plant & Equipment ₹781.98 Cr ₹798.17 Cr ₹799.2 Cr ₹727.12 Cr
Inventories ₹155.12 Cr ₹134.25 Cr ₹169.62 Cr ₹182.66 Cr
Trade Receivables ₹170.62 Cr ₹174.75 Cr ₹183.7 Cr ₹146.8 Cr
Cash & Equivalents ₹15.93 Cr ₹67.73 Cr ₹4.05 Cr ₹14.07 Cr
Equity (Net Worth) ₹3,882.23 Cr ₹4,030.48 Cr ₹4,052.58 Cr ₹4,114.31 Cr
Equity Share Capital ₹31.36 Cr ₹31.36 Cr ₹31.36 Cr ₹31.36 Cr
Borrowings (Non-current) ₹123.86 Cr ₹247.69 Cr ₹157.37 Cr ₹162.57 Cr
Borrowings (Current) ₹506.76 Cr ₹430.87 Cr ₹366.61 Cr ₹427.28 Cr
Total Debt (computed) ₹630.62 Cr ₹678.56 Cr ₹523.98 Cr ₹589.85 Cr
Current Liabilities ₹868.9 Cr ₹652.1 Cr ₹618.73 Cr ₹641.6 Cr
Total Liabilities ₹1,243.81 Cr ₹1,091.87 Cr ₹1,024.08 Cr ₹1,066.73 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹46.11 Cr ₹55.81 Cr ₹24.17 Cr -₹52.9 Cr ₹227.35 Cr
Investing Cash Flow ₹21.68 Cr -₹79.64 Cr ₹96.57 Cr ₹40.71 Cr -₹172.67 Cr
Financing Cash Flow -₹119.59 Cr ₹87.51 Cr -₹130.76 Cr ₹1.38 Cr -₹46.16 Cr
Capital Expenditure ₹26.99 Cr ₹54.9 Cr ₹36.14 Cr ₹123.24 Cr ₹39 Cr
Free Cash Flow (computed) ₹19.12 Cr ₹91 Lakh -₹11.97 Cr -₹176.14 Cr ₹188.35 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹51.8 Cr ₹63.68 Cr -₹10.02 Cr -₹10.81 Cr ₹8.52 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹68.72 Cr ₹39.68 Cr ₹60.3 Cr ₹62.86 Cr ₹106.1 Cr ₹97.04 Cr ₹93.29 Cr ₹103.41 Cr ₹111.26 Cr ₹86.82 Cr ₹59.72 Cr ₹69.55 Cr
Other Income ₹28.83 Cr ₹7.1 Cr ₹11.17 Cr ₹37.42 Cr ₹5.47 Cr -₹8.01 Cr ₹23.93 Cr ₹11.59 Cr -₹3.21 Cr ₹13.11 Cr ₹38.71 Cr ₹14.44 Cr
Total Income ₹97.55 Cr ₹46.78 Cr ₹71.47 Cr ₹100.28 Cr ₹111.57 Cr ₹89.03 Cr ₹117.22 Cr ₹115 Cr ₹108.05 Cr ₹99.93 Cr ₹98.43 Cr ₹83.99 Cr
Cost of Materials Consumed ₹13.35 Cr ₹17.92 Cr ₹11.19 Cr ₹13.21 Cr ₹22.75 Cr ₹28.46 Cr ₹33.55 Cr ₹32.25 Cr ₹26.48 Cr ₹31.52 Cr ₹27.1 Cr ₹22.6 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹3.53 Cr -₹19.11 Cr ₹96 Lakh -₹1.74 Cr ₹9.74 Cr -₹3.53 Cr -₹1.46 Cr ₹9.25 Cr ₹14.04 Cr ₹10.89 Cr -₹20.85 Cr ₹4.19 Cr
Employee Benefit Expense ₹21.18 Cr ₹21.43 Cr ₹21.74 Cr ₹22.28 Cr ₹21.09 Cr ₹23.43 Cr ₹22.66 Cr ₹22.97 Cr ₹23.22 Cr ₹23.55 Cr ₹22.45 Cr ₹22.32 Cr
Finance Costs ₹22.14 Cr ₹23.51 Cr ₹20.61 Cr ₹20.26 Cr ₹21.31 Cr ₹17.77 Cr ₹15.59 Cr ₹15.73 Cr ₹15.87 Cr ₹17.14 Cr ₹17.42 Cr ₹17.76 Cr
Depreciation & Amortisation ₹15.15 Cr ₹15.16 Cr ₹15.79 Cr ₹16.47 Cr ₹16.1 Cr ₹16.48 Cr ₹16.3 Cr ₹16.32 Cr ₹26.12 Cr ₹26.22 Cr ₹24.58 Cr ₹24.69 Cr
Other Expenses ₹29.68 Cr ₹22.94 Cr ₹22 Cr ₹25.68 Cr ₹31.99 Cr ₹25.72 Cr ₹25.14 Cr ₹24.04 Cr ₹35.95 Cr ₹17.69 Cr ₹33.94 Cr ₹25.46 Cr
Total Expenses ₹105.03 Cr ₹81.85 Cr ₹92.29 Cr ₹96.16 Cr ₹122.98 Cr ₹108.33 Cr ₹111.78 Cr ₹120.56 Cr ₹141.68 Cr ₹127.01 Cr ₹104.64 Cr ₹117.02 Cr
Profit Before Exceptional Items & Tax -₹7.48 Cr -₹35.07 Cr -₹20.82 Cr ₹4.12 Cr -₹11.41 Cr -₹19.3 Cr ₹5.44 Cr -₹5.56 Cr -₹33.63 Cr -₹27.08 Cr -₹6.21 Cr -₹33.03 Cr
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 -₹3.05 Cr ₹0
Profit Before Tax -₹7.48 Cr -₹35.07 Cr -₹20.82 Cr ₹4.12 Cr -₹11.41 Cr -₹19.3 Cr ₹5.44 Cr -₹5.56 Cr -₹33.63 Cr -₹27.08 Cr -₹9.26 Cr -₹33.03 Cr
Total Tax Expense -₹3.14 Cr -₹11.94 Cr -₹7.22 Cr ₹1.45 Cr -₹4.04 Cr -₹6.02 Cr -₹8.81 Cr -₹2.09 Cr -₹2.51 Cr -₹8.9 Cr -₹3.48 Cr -₹11.7 Cr
Net Profit -₹4.34 Cr -₹23.13 Cr -₹13.6 Cr ₹2.67 Cr -₹7.37 Cr -₹13.28 Cr ₹14.25 Cr -₹3.47 Cr -₹31.12 Cr -₹18.18 Cr -₹5.78 Cr -₹21.33 Cr
Other Comprehensive Income -₹54.88 Cr -₹6.09 Cr -₹18.63 Cr -₹30.26 Cr ₹65 Lakh ₹5.18 Cr -₹18.61 Cr ₹55 Lakh ₹39.63 Cr -₹33.52 Cr ₹2.33 Cr ₹6.25 Cr
Total Comprehensive Income -₹59.22 Cr -₹29.22 Cr -₹32.23 Cr -₹27.59 Cr -₹6.72 Cr -₹8.1 Cr -₹4.36 Cr -₹2.92 Cr ₹8.51 Cr -₹51.7 Cr -₹3.45 Cr -₹15.08 Cr
EBITDA (computed) ₹29.81 Cr ₹3.6 Cr ₹15.58 Cr ₹40.85 Cr ₹26 Cr ₹14.95 Cr ₹37.33 Cr ₹26.49 Cr ₹8.36 Cr ₹16.28 Cr ₹35.79 Cr ₹9.42 Cr
Basic EPS ₹-0.28 ₹-1.47 ₹-0.87 ₹0.17 ₹-0.47 ₹-0.85 ₹0.91 ₹-0.22 ₹-1.98 ₹-1.16 ₹-0.37 ₹-1.36
Diluted EPS ₹-0.28 ₹-1.47 ₹-0.87 ₹0.17 ₹-0.47 ₹-0.85 ₹0.91 ₹-0.22 ₹-1.98 ₹-1.16 ₹-0.37 ₹-1.36
Latest 12 quarters shown of 25 on record.
Segment · FY 2022 (annual) Revenue Result (PBIT) Assets Liabilities
CRAMS ₹0 ₹0 - -
OTHERS ₹0 ₹0 - -
Want more history and ratios?
You're viewing the latest exchange-filed financials for Dishman Carbogen Amcis Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Dishman Carbogen Amcis Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 59.32%, foreign institutional investors hold 7.45%, domestic institutional investors hold 1.63%, retail and other public shareholders hold 31.60% of Dishman Carbogen Amcis Limited. The company had 49,009 shareholders on record.

Promoters: 59.32%DII (Domestic Institutional): 1.63%FII (Foreign Institutional): 7.45%Retail & Others: 31.60%
Mar 2026
QUARTER
59.32% Promoters
1.63% DII (Domestic Institutional)
7.45% FII (Foreign Institutional)
31.60% Retail & Others
Promoter holding - history
Now 59.32% · Mar 2026High 63.21% · Jun 2020Low 59.32% · Mar 2021
58%59.8%61.5%63.3%65%Sep 2017Sep 2019Jun 2021Jun 2023Jun 2025Sep 2017: 61.40%Dec 2017: 61.40%Mar 2018: 61.40%Jun 2018: 61.40%Sep 2018: 61.40%Dec 2018: 61.40%Mar 2019: 61.40%Jun 2019: 61.40%Sep 2019: 61.40%Dec 2019: 61.40%Mar 2020: 63.17%Apr 2020: 63.17%Jun 2020: 63.21%Sep 2020: 63.21%Dec 2020: 61.93%Mar 2021: 59.32%Jun 2021: 59.32%Sep 2021: 59.32%Dec 2021: 59.32%Mar 2022: 59.32%Jun 2022: 59.32%Sep 2022: 59.32%Dec 2022: 59.32%Mar 2023: 59.32%Jun 2023: 59.32%Sep 2023: 59.32%Dec 2023: 59.32%Mar 2024: 59.32%Jun 2024: 59.32%Sep 2024: 59.32%Dec 2024: 59.32%Mar 2025: 59.32%Jun 2025: 59.32%Sep 2025: 59.32%Dec 2025: 59.32%Mar 2026: 59.32%63.21%59.32%59.32%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters59.32%59.32%59.32%59.32%59.32%59.32%
Public40.68%40.68%40.68%40.68%40.68%40.68%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
Promoters59.32%59.32%59.32%59.32%59.32%59.32%63.17%61.40%61.40%
Public40.68%40.68%40.68%40.68%40.68%40.68%36.83%38.60%38.60%
Promoter change (YoY, %pts)+0.00+0.00+0.00+0.00+0.00-3.85+1.77+0.00-

Board & Governance of Dishman Carbogen Amcis Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Dishman Carbogen Amcis Limited has 6 directors - 3 independent and 2 executive.

DirectorPositionOn board sinceListed boards
Deohooti Janmejay Vyas Executive Director 2016-09-03 1
Arpit Janmejay Vyas Executive Director · MD 2014-06-01 1
Dhaval Rameshchandra Shah Non-Executive - Non Independent Director 2025-08-12 1
Kulin Nalinkant Shah Non-Executive - Independent Director 2024-11-13 1
Hemantkumar Jayantiprasad Bhatt Non-Executive - Independent Director 2025-04-01 1
Margie Parikh Non-Executive - Independent Director 2025-04-01 1
Board Committees
CommitteeMembers
Audit Committee Hemantkumar Jayantiprasad Bhatt (Chairperson), Kulin Nalinkant Shah, Margie Parikh
Nomination and remuneration committee Hemantkumar Jayantiprasad Bhatt (Chairperson), Kulin Nalinkant Shah, Margie Parikh
Stakeholders Relationship Committee Hemantkumar Jayantiprasad Bhatt (Chairperson), Kulin Nalinkant Shah, Arpit Janmejay Vyas
Risk Management Committee Arpit Janmejay Vyas (Chairperson), Harshil Ramakant Dalal, Hemantkumar Jayantiprasad Bhatt

Group Structure of Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited has 2 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Dishman Carbogen Amcis Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Dishman Biotech Limited U24231GJ1995PLC028060 -
Dishman Medicare Limited (Formerly Known As Visible Investment Limited) U65990GJ2021PLC122015 -

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Dishman Carbogen Amcis Limited

Open charges
₹1,609.35 Cr
Satisfied charges
₹879.25 Cr
Breakdown by lending institutions
Others₹1,557.41 Cr
Axis Bank Limited₹47.97 Cr
Hdfc Bank Limited₹3.92 Cr
Madhya Pura Mercentile Co.Op. Bank₹0.05 Cr
Latest charge details
DateLenderAmountStatus
30 Jun 2026 Others ₹42.85 Cr Open
30 Mar 2026 Others ₹60 Cr Open
10 Feb 2026 Others ₹75 Cr Open
17 Jan 2026 Others ₹50 Cr Open
13 Jan 2026 Others ₹20 Cr Open

Total charge records: 47 View all charges

Employees and EPFO Compliance at Dishman Carbogen Amcis Limited

View historical data on people associated with Dishman Carbogen Amcis Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Dishman Carbogen Amcis Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Dishman Carbogen Amcis Limited

Premium access

GST registrations and filing compliance for Dishman Carbogen Amcis Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Dishman Carbogen Amcis Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Dishman Carbogen Amcis Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Dishman Carbogen Amcis Limited

Premium access

MSME payment history for Dishman Carbogen Amcis Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Dishman Carbogen Amcis Limited

Premium access

Corporate group structure for Dishman Carbogen Amcis Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Dishman Carbogen Amcis Limited

Premium access

MCA filings and documents for Dishman Carbogen Amcis Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Dishman Carbogen Amcis Limited

Charges
30 Jun 2026
A charge with Others amounted to Rs. 42.85 Cr with Charge ID 101316108 was registered on 30 Jun 2026.
Charges
30 Mar 2026
A charge with Others amounted to Rs. 60.00 Cr with Charge ID 101278652 was registered on 30 Mar 2026.
Charges
10 Feb 2026
A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101242915 was registered on 10 Feb 2026.
Charges
29 Jan 2026
A charge registered on 18 May 2023 via Charge ID 100729014 with Others was fully satisfied on 29 Jan 2026.
Charges
29 Jan 2026
A charge registered on 10 Nov 2022 via Charge ID 100646576 with Others was fully satisfied on 29 Jan 2026.
Charges
29 Jan 2026
A charge registered on 21 Dec 2021 via Charge ID 100534456 with Others was fully satisfied on 29 Jan 2026.

Recent News on Dishman Carbogen Amcis Limited

Frequently Asked Questions about Dishman Carbogen Amcis Limited

Dishman Carbogen Amcis Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 17 July 2007 (19+ years old) and is registered under CIN L74900GJ2007PLC051338. Listed on BSE: 540701 and NSE: DCAL.

Dishman Carbogen Amcis Limited reported revenue of ₹2,931.9 Cr for FY 2026 (up 8.13% YoY) based on consolidated NSE filings.

The current directors and KMP of Dishman Carbogen Amcis Limited are:

The primary industry of Dishman Carbogen Amcis Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Yes. Dishman Carbogen Amcis Limited is listed on both BSE (code: 540701) and NSE (symbol: DCAL).

Dishman Carbogen Amcis Limited can be reached at the registered office: Dishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058, or through the website dishmangroup.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available